Tag: Prescription Drugs
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke...
Findings seen in patients with ischemic stroke; associations were significant after multivariable adjustment
Medication Abortion Before Confirmed Intrauterine Pregnancy Noninferior
Medication abortion before confirmed intrauterine pregnancy is noninferior to standard, delayed treatment for complete abortion
Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer
Inavolisib leads to significantly longer progression-free survival, with no increase seen in incidence of toxic events
ASN: Atrasentan Significantly and Clinically Meaningfully Cuts Proteinuria
Findings seen in patients with IgA nephropathy, compared with placebo
ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma
Inhaled corticosteroid with short-acting β agonists or long-acting β agonist formoterol linked to reduction in exacerbations, improved control
Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
Guidelines include 52 recommendations on evaluation, pharmacotherapy, invasive interventions, and nonpharmacologic interventions
ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With Rifaximin
Rifaximin monotherapy reduces risk for breakthrough OHE episode and results in a lower mortality rate than lactulose monotherapy
ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression
ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
Second study shows that only 14 percent of patients correctly identified symptoms requiring epinephrine
ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema
Reduction of 75 and 77 percent seen in estimated mean monthly attack rate with 25-mg, 50-mg NTLA-2002 versus placebo